JPS6324974B2 - - Google Patents

Info

Publication number
JPS6324974B2
JPS6324974B2 JP25557684A JP25557684A JPS6324974B2 JP S6324974 B2 JPS6324974 B2 JP S6324974B2 JP 25557684 A JP25557684 A JP 25557684A JP 25557684 A JP25557684 A JP 25557684A JP S6324974 B2 JPS6324974 B2 JP S6324974B2
Authority
JP
Japan
Prior art keywords
rhodanine
carboxymethyl
aldose reductase
reductase inhibitor
inhibitor according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
JP25557684A
Other languages
English (en)
Japanese (ja)
Other versions
JPS60156387A (ja
Inventor
Tadao Tauchi
Masanori Kawamura
Akio Ajima
Tetsuya Mori
Masaki Hayashi
Hiroshi Terajima
Fumio Hirata
Takeshi Morimura
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ono Pharmaceutical Co Ltd
Original Assignee
Ono Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ono Pharmaceutical Co Ltd filed Critical Ono Pharmaceutical Co Ltd
Priority to JP25557684A priority Critical patent/JPS60156387A/ja
Publication of JPS60156387A publication Critical patent/JPS60156387A/ja
Publication of JPS6324974B2 publication Critical patent/JPS6324974B2/ja
Granted legal-status Critical Current

Links

Landscapes

  • Thiazole And Isothizaole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP25557684A 1984-12-05 1984-12-05 ロダニン誘導体を有効成分とするアルド−ス還元酵素阻害剤 Granted JPS60156387A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP25557684A JPS60156387A (ja) 1984-12-05 1984-12-05 ロダニン誘導体を有効成分とするアルド−ス還元酵素阻害剤

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP25557684A JPS60156387A (ja) 1984-12-05 1984-12-05 ロダニン誘導体を有効成分とするアルド−ス還元酵素阻害剤

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP55115641A Division JPS5740478A (en) 1980-08-22 1980-08-22 Rhodanine derivative, its preparation and aldose reductase inhibitor containing rhodanine derivative

Publications (2)

Publication Number Publication Date
JPS60156387A JPS60156387A (ja) 1985-08-16
JPS6324974B2 true JPS6324974B2 (https=) 1988-05-23

Family

ID=17280634

Family Applications (1)

Application Number Title Priority Date Filing Date
JP25557684A Granted JPS60156387A (ja) 1984-12-05 1984-12-05 ロダニン誘導体を有効成分とするアルド−ス還元酵素阻害剤

Country Status (1)

Country Link
JP (1) JPS60156387A (https=)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH02124878A (ja) * 1988-11-02 1990-05-14 Kaken Pharmaceut Co Ltd チアゾリジン‐２，４‐ジオン誘導体およびその製造法
US5116855A (en) * 1989-05-19 1992-05-26 Nisshin Flour Milling Co., Ltd. Rhodanine derivatives and pharmaceutical compositions
WO2005026127A1 (ja) * 2003-09-11 2005-03-24 Institute Of Medicinal Molecular Design. Inc. プラスミノゲンアクチベータインヒビター－１阻害剤

Also Published As

Publication number Publication date
JPS60156387A (ja) 1985-08-16

Similar Documents

Publication Publication Date Title
US4464382A (en) Rhodanine derivatives, process for their preparation, and aldose reductase inhibitor containing the rhodanine derivatives as active ingredient
DE60019919T2 (de) Hydrochloride kondensierter heterozyklen
US5225426A (en) Thiazolidine-2,4-dione compound and method of treatment of diabetic complications
FR2889190A1 (fr) Nouveaux derives d'imidazoles carboxamides comme inhibiteurs de fructose -1,6-biphosphatase et compositions pharmaceutiques les contenant
CZ283339B6 (cs) Použití thiazolidinových derivátů pro výrobu léčivého přípravku pro léčení zhoršené tolerance glukosy pro zabránění nebo zpoždění nástupu diabetes mellitus nezávislé na inzulinu
JP3194964B2 (ja) 臓器または組織保護剤
CA2617248C (en) Methods for treating hypertension
US4791126A (en) Rhodanine derivatives, process for their preparation, and aldose reductase inhibitor containing the rhodanine derivatives as active ingredients
JP4306825B2 (ja) インスリン抵抗性が関与する血管機能異常を伴う疾患の予防または治療剤
JPS6324974B2 (https=)
CA2241856C (en) Agent for prophylaxis and treatment of diabetic complications
JP3126541B2 (ja) ベンゾチアゾール誘導体、その製法及びその用途
JPH03215426A (ja) 血糖上昇抑制剤
US4178386A (en) Inhibitors of glycolic acid oxidase
WO2000024397A1 (en) Immunomodulatory drug composition
US4512994A (en) Long-acting theophylline in medicinal form
RU2093155C1 (ru) Применение 5-[2-хлор-1-гидроксиэтил]-4-метилтиазола для снижения поражения нейронов, подавления конвульсий и снижения двигательной активности
JPS6081127A (ja) 食欲抑制剤
KR100219972B1 (ko) 빈혈과 관련된 조직 손상 감소 방법
JPS5835186A (ja) ジカルボキシアミノチアゾール誘導体およびそれを含有する免疫調節組成物
JP3195455B2 (ja) キノリン−３−酢酸誘導体、その製造法と用途
EP0337350B1 (en) Use of dimethylheptylphenyl butanoyl ethanolamine in treatment of hyperuricemia
JPS6360727B2 (https=)
US8685952B2 (en) Method for the treatment of diabetes
JP4426654B2 (ja) 免疫調節用医薬組成物